A1298C methylenetetrahydrofolate reductase mutation and coronary artery disease: relationships with C677T polymorphism and homocysteine/folate metabolism

[1]  H. Blom,et al.  A second common variant in the methylenetetrahydrofolate reductase (MTHFR) gene and its relationship to MTHFR enzyme activity, homocysteine, and cardiovascular disease risk , 2001, Journal of Molecular Medicine.

[2]  O. Aras,et al.  C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease. , 2001, Clinical chemistry.

[3]  G. M. Taylor,et al.  Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[4]  V. Gudnason,et al.  The effect of the C677T and A1298C polymorphisms in the methylenetetrahydrofolate reductase gene on homocysteine levels in elderly men and women from the British regional heart study. , 2001, Atherosclerosis.

[5]  G. Wells,et al.  Neonatal and fetal methylenetetrahydrofolate reductase genetic polymorphisms: an examination of C677T and A1298C mutations. , 2000, American journal of human genetics.

[6]  W. Hörl,et al.  Effect of MTHFR 1298A-->C and MTHFR 677C-->T genotypes on total homocysteine, folate, and vitamin B(12) plasma concentrations in kdiney graft recipients. , 2000, Journal of the American Society of Nephrology : JASN.

[7]  Y. Friedlander,et al.  The association between two common mutations C677T and A1298C in human methylenetetrahydrofolate reductase gene and the risk for diabetic nephropathy in type II diabetic patients. , 2000, The Journal of nutrition.

[8]  D. Girelli,et al.  Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease. , 2000, The New England journal of medicine.

[9]  S. Vollset,et al.  The controversy over homocysteine and cardiovascular risk. , 2000, The American journal of clinical nutrition.

[10]  D. Quilliot,et al.  The effect of 677C-->T and 1298A-->C mutations on plasma homocysteine and 5,10-methylenetetrahydrofolate reductase activity in healthy subjects. , 2000, The British journal of nutrition.

[11]  T. Marquardt,et al.  Linkage disequilibrium of the common mutations 677C > T and 1298A > C of the human methylenetetrahydrofolate reductase gene as proven by the novel polymorphisms 129C > T, 1068C > T , 2000, European Journal of Pediatrics.

[12]  J. G. Donnelly.  The 1298(A-->C) mutation of methylenetetrahydrofolate reductase should be designated to the 1289 position of the gene. , 2000, American journal of human genetics.

[13]  H. Blom,et al.  Reply to Donnelly , 2000 .

[14]  A. Ziegler,et al.  Linkage disequilibrium of MTHFR genotypes 677C/T-1298A/C in the German population and association studies in probands with neural tube defects(NTD). , 1999, American journal of medical genetics.

[15]  G. Morgan,et al.  Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[16]  R. Matalon,et al.  Methylenetetrahydrofolate reductase (MTHFR): the incidence of mutations C677T and A1298C in the Ashkenazi Jewish population. , 1999, American journal of medical genetics.

[17]  Y. Friedlander,et al.  A common mutation A1298C in human methylenetetrahydrofolate reductase gene: association with plasma total homocysteine and folate concentrations. , 1999, The Journal of nutrition.

[18]  G. Hankey,et al.  Homocysteine and vascular disease , 1999, The Lancet.

[19]  L. Brudin,et al.  Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis. , 1998, Circulation.

[20]  R. Rozen,et al.  A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. , 1998, Molecular genetics and metabolism.

[21]  E. Trabetti,et al.  Methylenetetrahydrofolate reductase C677T mutation, plasma homocysteine, and folate in subjects from northern Italy with or without angiographically documented severe coronary atherosclerotic disease: evidence for an important genetic-environmental interaction. , 1998, Blood.

[22]  F. Gabreëls,et al.  A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? , 1998, American journal of human genetics.

[23]  E. Sacchi,et al.  High Frequency of the C677T Mutation in the Methylenetetrahydrofolate Reductase (MTHFR) Gene in Northern Italy , 1997, Thrombosis and Haemostasis.

[24]  R. Rozen.  Genetic Predisposition to Hyperhomocysteinemia: Deficiency of Methylenetetrahydrofolate Reductase (MTHFR) , 1997, Thrombosis and Haemostasis.

[25]  A. Viel,et al.  Loss of heterozygosity at the 5,10-methylenetetrahydrofolate reductase locus in human ovarian carcinomas. , 1997, British Journal of Cancer.

[26]  P. Frosst,et al.  Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[27]  W. Willett,et al.  Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. , 1996, Circulation.

[28]  M. Margaglione,et al.  Elevated total plasma homocysteine and 677C-->T mutation of the 5,10-methylenetetrahydrofolate reductase gene in thrombotic vascular disease. , 1996, American journal of human genetics.

[29]  P. Wilson,et al.  Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. , 1993, JAMA.

[30]  E. Falk,et al.  Homocysteine and atherothrombosis , 2001, Lipids.

[31]  W. Hörl,et al.  Effect of MTHFR 1298 A 3 C and MTHFR 677 C 3 T Genotypes on Total Homocysteine , Folate , and Vitamin B 12 Plasma Concentrations in Kidney Graft Recipients , 2000 .

[32]  R. Matthews,et al.  The structure and properties of methylenetetrahydrofolate reductase from Escherichia coli suggest how folate ameliorates human hyperhomocysteinemia , 1999, Nature Structural Biology.

[33]  J. Selhub,et al.  Homocysteine and thrombotic disease. , 1997, Blood.

[34]  I. Rosenberg,et al.  Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. , 1996, Circulation.

[35]  R. Matthews,et al.  A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase , 1995, Nature Genetics.

[36]  Y. Sako,et al.  Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. , 1987, Journal of chromatography.